A team of scientists from Thailand has developed a curcumin-containing oro-nasal film spray, which shows potential antiviral activity and mucosal immunity-boosting activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses.
The study is published in the Virology Journal.
Background
SARS-CoV-2, the causative pathogen of coronavirus disease 2019 (COVID-19) pandemic, is an enveloped RNA virus that primarily causes mild to severe respiratory infections. Influenza virus types A, B, and C are also RNA viruses that cause seasonal respiratory infections commonly known as flu.
Infections caused by SARS-CoV-2 and influenza viruses are associated with high mortality rates. Although both viruses can affect people from all age groups, more deadly infections occur in older people and immunocompromised patients.
Bioactive compounds derived from plants have gained immense attention in the medical community because of their potent antioxidant, anti-inflammatory, anticancer, and antimicrobial activities. Curcumin is a promising plant-derived compound that shows potential antiviral and immunomodulatory activities against SARS-CoV-2 and influenza A virus.
In this study, scientists have developed an oro-nasal film spray containing curcumin and tested its antiviral and mucosal innate immunity-boosting activities against SARS-CoV-2 and influenza viruses.
Various actions of the curcumin film spray. Formulation of curcumin film spray shows various actions on prevention of COVID-19; First, it can inhibit SARS-CoV-2 infection by inhibiting ACE-2 binding. Second, the film spray upregulates the production of antimicrobial peptides LL-37 and HD-5 produced by oral epithelial cells, which have been previously reported to inhibit SARS-CoV-2 infection in silico. Third, the film spray induced the production of antiinflammatory cytokines IL-6 and TNF-α produced by oral epithelial cells. In addition, the film spray inhibits influenza virus infection.The infographic was designed by BioRender.com (https://app.biorender.com)
Study design
The antiviral activity of oro-nasal film spray containing 10 µg/ml of curcumin was tested against SARS-CoV-2, influenza A/H1N1, influenza A/H3N2, and influenza B by plaque reduction assay. Different cytotoxicity assays were conducted to determine the viability of oral keratinocytes, nasal epithelial cells, and other tested cell lines in response to the film spray.
Enzyme-linked Immunosorbent assay (ELISA) was conducted to determine the levels of oral and nasal innate immune markers (LL-37, HD-5, and human β defensin 2) in response to the film spray. Moreover, the levels of pro-inflammatory markers (interleukins, tumor necrosis factor, and interferon) were also determined.

Important observations
The fundamental physical properties of the curcumin formulation, including color, pH, droplet size, osmolarity, and viscosity, were tested in the study. The findings showed no alteration in properties after freeze-thawing, indicating the stability of the formulation.
Regarding the cytotoxicity and antiviral activity of curcumin, the study found that the compound is capable of inhibiting viral infection at 6.25 µg/ml concentration by blocking the interaction between SARS-CoV-2 spike protein and human cell membrane receptor angiotensin-converting enzyme 2 (ACE2). At the tested concentration, no cytotoxic effect of curcumin compound was observed.
Similar to the curcumin compound, curcumin-containing film spray showed significant efficacy in inhibiting viral infection at 10 µg/ml concentration without affecting cell viability. The selectivity index of curcumin compound and curcumin-containing film spray was estimated to be 1.23 and 1.68, respectively. The selectivity index defines the window between cytotoxicity and antiviral activity. The higher the index value, the more effective and safer a drug would be during an in vivo treatment for a given viral infection.
Regarding antiviral activities against all tested viruses, the study found that curcumin film spray has the highest inhibitory activity against SARS-CoV-2, followed by influenza B virus and influenza A/H1N1 virus. However, the spray showed only a slight inhibitory activity against influenza A/H3N2 virus.
Effect of curcumin film spray on mucosal innate immunity
The estimation of oral and nasal innate immunity markers revealed that curcumin film spray could significantly induce the secretion of antimicrobial peptides LL-37 and HD-5 and reduce the secretion of hBD-2 protein by oral keratinocytes. However, no upregulated secretion of antimicrobial peptides from nasal epithelial cells was detected in response to the curcumin spray.
Regarding inflammatory cytokines, oral keratinocytes produced an upregulated amount of interleukin 6 and tumor necrosis factor-alpha in response to curcumin film spray. However, nasal epithelial cells did not experience such an effect.
Study significance
The study describes the antiviral and immunomodulatory activities of a novel curcumin-containing oro-nasal film spray. The spray exhibits significant inhibitory activity against SARS-CoV-2 and influenza viruses without inducing cytotoxicity at therapeutic doses. The spray is also capable of inducing the secretion of antimicrobial peptides and anti-inflammatory mediators by oral keratinocytes.
Overall, the study indicates that this curcumin film spray may be effectively used to block viral entry into host cells, prevent lung injury, and reduce disease severity.
- Nittayananta W. 2024. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity. Virology Journal. https://virologyj.biomedcentral.com/articles/10.1186/s12985-023-02282-x
News
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]















